DMKJ
CNTB

David M. Knott Jr’s Connect Biopharma Holdings CNTB Stock Holding History

David M. Knott Jr’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.02M Buy
387,835
+187,835
+94% +$490K 0.6% 35
2025
Q4 		$564K Buy
+200,000
New +$427K 0.26% 48

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

David M. Knott Jr's CNTB Position: Q1 2026 in Review

David M. Knott Jr increased its Connect Biopharma Holdings (CNTB) stake by 94% in Q1 2026, buying an estimated $490K and bringing the position to 387,835 shares worth $1.02M. The position accounts for 0.6% of the portfolio, ranked #35.

David M. Knott Jr first reported a position in CNTB in Q4 2025 and has held it in 2 quarters since. 41 funds tracked by Wall St. Rank hold CNTB as of Q1 2026.

  • David M. Knott Jr held 387,835 shares of Connect Biopharma Holdings worth $1.02M as of Q1 2026.
  • David M. Knott Jr bought 187,835 Connect Biopharma Holdings shares in Q1 2026, an estimated $490K.
  • Connect Biopharma Holdings made up 0.6% of David M. Knott Jr's portfolio in Q1 2026, its #35 holding.
  • David M. Knott Jr first reported a position in Connect Biopharma Holdings in Q4 2025 and has held it in 2 quarters since.
  • 41 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2026.

Based on David M. Knott Jr's 13F filing for Q1 2026, filed 14 May 2026.